Response of dogs to short-term infusions of carbohydrate- or lipid-based parenteral nutrition.
Parenteral nutrition (PN) is used to support intensive care patients. The risk for adverse metabolic effects depends on the composition of infused solutions and the duration of application. The present study in dogs compares metabolic and endocrine effects of two infusion solutions, with either triglycerides or glucose being the major energy sources, administered in a comparatively short infusion period (10 h/day). PN was administered for 9 days to two groups of five adult dogs to meet energy maintenance requirements. In group PN-LIP 61% of the total energy was derived from lipids and 22% from carbohydrates, compared with 21 and 62% in group PN-GLUC. Among routine haematology and clinical chemistry the plasma levels of glucose, triglycerides, insulin, insulin-like growth factor-I (IGF-I), glucagon, 3,5,3'-triiodothyronine and thyroxin were measured in non-infused dogs and at 2, 4, 6, and 8 h after the start of infusion at days 2 and 8 of the study. Infusions protocols did not cause gross metabolic aberrations. During the actual infusions glucose, triglyceride and insulin concentrations were elevated, each depending on the infusion solution. Concentrations of IGF-I, glucagon, 3,5,3'-triiodothyronine, thyroxin and cortisol did not change significantly. In conclusion short infusion periods of 10 h per day were tolerated by healthy dogs without adverse signs, which could improve practicability of PN also in clinical cases.
Zentek
J
J
Institute of Animal Nutrition, Veterinary School of Hannover, Bischofsholer Damm 15, D 30173 Hannover, Germany. juergen.Zentek@vu-wien.ac.at
Stephan
I
I
Kramer
S
S
Görig
C
C
Blum
J W
JW
Mischke
R
R
Nolte
I
I
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D004040:Dietary Carbohydrates / Q000008:administration & dosage / Q000494:pharmacology*; D004041:Dietary Fats / Q000008:administration & dosage / Q000494:pharmacology*; D004285:Dogs / Q000097:blood / Q000378:metabolism*; D005260:Female; D005934:Glucagon / Q000097:blood / Q000187:drug effects; D006854:Hydrocortisone / Q000097:blood; D007262:Infusions, Intravenous / Q000662:veterinary; D007328:Insulin / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000187:drug effects / Q000378:metabolism; D010288:Parenteral Nutrition / Q000662:veterinary*; D012016:Reference Values; D013974:Thyroxine / Q000097:blood / Q000187:drug effects; D014280:Triglycerides / Q000097:blood; D014284:Triiodothyronine / Q000097:blood / Q000187:drug effects
D001786:Blood Glucose; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D007328:Insulin; D014280:Triglycerides; D014284:Triiodothyronine; D007334:Insulin-Like Growth Factor I; D005934:Glucagon; D013974:Thyroxine; D006854:Hydrocortisone